ACE2 and thrombophilia: In addition to traditional vascular mechanisms in COVID-19 patients, dysfunction of the renin-angiotensin system (RAS) due to virus binding to angiotensin-converting enzyme -2 (ACE2), hypercoagulability, severe inflammation, and cardiac dysfunction may lead to secondary cardiovascular and cerebrovascular effects [11-13].